Disc Medicine (IRON) Year-over-year earnings per share growth for the last twelve months

Corporate emblem and logo of Disc Medicine, Inc. (IRON)

Disc Medicine, Inc. (IRON) specializes in hematological drugs for the treatment of anemia. Tracking the quarterly EPS dynamics on GURU.Markets, we note that 13.80 captures the current value of the indicator. Production facilities and laboratories are operating normally. However, geopolitical tensions and sanctions create risks for component logistics and the conduct of international clinical trials.

discmedicine.com (IRON) - Year-over-year earnings per share growth for the last 12 months from 04/28/2023 to 11/17/2026

Summary analytical data breakdowns for discmedicine.com (IRON)

- market value and analyst target forecast:
Analysis of all company metrics:Disc Medicine Pharma - IRON
Flagship merchandise of Disc Medicine, Inc.

For Disc Medicine, Inc. (IRON), quarterly net income per share dynamics serve as an indicator of the effectiveness of monetizing its developments. This metric measures the percentage change in profit over the last three months relative to the previous period. The calculation captures the growth or contraction rate of income per security. For a biotech company, this is a critical marker of the viability of experimental drugs. Stagnation of this indicator may signal failures in blood research, threatening the company's capitalization.

Main competitors

tgtherapeutics.com (TGTX) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Arcellx Therapeutics (ACLX)|Year-over-year earnings per share growth for the last twelve months Syndax Pharmaceuticals Inc|Earnings per share growth in annualized terms for the last twelve months Kura Oncology, Inc. KURA|Quarterly EPS earnings growth ADCT|Foghorn Therapeutics Inc. - Year-over-year earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months vorbio.com VOR|NKTX: Year-over-year earnings per share growth for the last 12 months|COEP - Year-over-year earnings per share growth for the last twelve months|Actinium Pharmaceuticals, Inc. (ATNM) - Year-over-year net earnings per share growth for the last 12 months|ESLA (Estrella Immunopharma) - Year-over-year net earnings per share growth for the last 12 months|CASI - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Marker Bio|Quarterly EPS earnings growth IN8bio, Inc.|Year-over-year earnings per share growth for the last twelve months Eterna Therapeutics Inc (ERNA)|Year-over-year net earnings per share change for the last twelve months gtbiopharma.com|Quarterly EPS earnings growth APTO (Aptose Biosciences)|Quarterly EPS earnings growth Bio-Path BPTH|MEI Pharma Inc - Quarterly EPS earnings growth|VINC (Vincerx Pharma Inc.) - Year-over-year earnings per share growth for the last 12 months